Stephan Klaschka is an awarded innovation executive, strategy consultant, and entrepreneur with over 25 years of international work experience across numerous industries and company sizes ranging from FORBES Global 20 to startups. Stephan held senior leadership positions in business operations, strategy, regulatory compliance, and innovation with Boehringer Ingelheim, a FORBES Global 500 and Top 20 biopharmaceutical company, leaving as Director of Global Innovation Management and Strategy. In this first-of-its-kind position, Stephan's work was central to the new growth rejuvenation strategy as........Read More
Briefly outline of obstacles to innovation in larger organizations.
Present disruptive approaches to overcome them by building an effective and proven innovation ecosystem with specific examples including intrapreneuring, open innovation and internal corporate venturing that seek to effectively shortcut the convoluted and inflexible processes to identify and seize new business growth as well as savings opportunities.
Examples lead into interactive questions, reflection, and discussion with the audience.
Why should you attend?
The pharmaceutical, life-sciences and healthcare industries observe the arrival of "Pharma 3.0" or "business beyond the pill"somewhat puzzled.
It comes with fundamental changes to the business environment under the new paradigm of outcomes focus and patient centricity.
Large pharmaceutical organizations struggle finding successful approaches to harness new opportunities when facing the questions:
Areas Covered in the Session:
Who can Benefit:
This introductory program is for managers and employees interested in learning about intrapreneuring as well as innovation professionals involved in strategic, disruptive, transformational or intrapreneurial innovation functions in larger organizations. The program is of benefit for both, seasoned and newly appointed innovation leaders/managers, as well as those aspiring to lead innovation in a large organization.
While the examples for innovation obstacles mostly come from pharma, the program is not limited to pharma/healthcare but all industries and organizations, since intrapreneuring is not limited to any industry or organization.
Job-titles may include: